Download details
Kitov Pharmaceuticals KIT 302 Drug Candidate Meets Primary Efficacy Endpoint in Phase III Clinical Trial
Created
Monday, 27 June 2016 00:11
Changed
Monday, 27 June 2016 00:11
Size
154.38 KB
Rating
Created by
Jim Davis
Downloads
613